[Concept of the management and diagnosis for ischemic cardiomyopathy (ICM)].

M. Sakakibara,H. Tsutsui

Abstract:

What problem does this paper attempt to address?

PolSim: Automatic Policy Validation via Meta-Data Flow Simulation

Mohamed Alzayat,P. Druschel,D. Garg

2016-09-27

Abstract:Every year millions of confidential data records are leaked accidentally due to bugs, misconfiguration, or operator error. These incidents are common in large, complex, and fast evolving data processing systems. Ensuring compliance with data policies is a major challenge. Thoth [17] is an information flow control system that uses coarse-grained taint tracking to control the flow of data. This is achieved by enforcing relevant declarative policies at processes boundaries. This enforcement is applicable regardless of bugs, misconfiguration, and compromises in application code, or actions by unprivileged operators. Designing policies that make sure all and only compliant flows are allowed remains a complex and error-prone process. In this paper, we introduce PolSim, a simulation tool that aids system policy designers by validating the provided policies and systematically ensuring that the system allows all and only expected flows. Our proposed simulator approximates the dynamic run-time environment, semi-automatically suggests internal flow policies based on data flow, and provides debugging hints to help policy designers develop a working policy for the intended system before deployment.
Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City

Ana Luisa Sosa,Sonia MD Brucki,Lucia Crivelli,Francisco Javier Lopera,Daisy M Acosta,Juliana Acosta‐Uribe,Diego Aguilar,Sara G Aguilar‐Navarro,Ricardo F Allegri,Paulo HF Bertolucci,Ismael L Calandri,Maria C Carrillo,Patricio Alexis Chrem Mendez,Mario Cornejo‐Olivas,Nilton Custodio,Andrés Damian,Leonardo Cruz de Souza,Claudia Duran‐Aniotz,Adolfo M García,Carmen García‐Peña,Mitzi M Gonzales,Lea T Grinberg,Agustin M Ibanez,Maryenela Zaida Illanes‐Manrique,Clifford R Jack,Jorge Mario Leon‐Salas,Jorge J Llibre‐Guerra,José Luna‐Muñoz,Diana Matallana,Bruce L Miller,Lorina Naci,Mario A Parra,Margaret Pericak‐Vance,Stefanie D Piña‐Escudero,Elisa de Paula França Resende,John M Ringman,Gustavo Sevlever,Andrea Slachevsky,Claudia Kimie Suemoto,Victor Valcour,Andres Villegas‐Lanau,Mônica S Yassuda,Simin Mahinrad,Claire Sexton

DOI: https://doi.org/10.1002/alz.13850

2024-05-29

Alzheimer s & Dementia

Abstract:INTRODUCTION While Latin America (LatAm) is facing an increasing burden of dementia due to the rapid aging of the population, it remains underrepresented in dementia research, diagnostics, and care. METHODS In 2023, the Alzheimer's Association hosted its eighth satellite symposium in Mexico, highlighting emerging dementia research, priorities, and challenges within LatAm. RESULTS Significant initiatives in the region, including intracountry support, showcased their efforts in fostering national and international collaborations; genetic studies unveiled the unique genetic admixture in LatAm; researchers conducting emerging clinical trials discussed ongoing culturally specific interventions; and the urgent need to harmonize practices and studies, improve diagnosis and care, and use affordable biomarkers in the region was highlighted. DISCUSSION The myriad of topics discussed at the 2023 AAIC satellite symposium highlighted the growing research efforts in LatAm, providing valuable insights into dementia biology, genetics, epidemiology, treatment, and care.

clinical neurology
S19: Aging and Dementia problems in Latin America and the Caribbean: education, healthy ageing and recent research linked to microglia and microbiota

Cecilia M Serrano,Tomas León,Alicia Kabanchik,Maria Andrea Carosella

DOI: https://doi.org/10.1017/s1041610224001224

IF: 7.191

2024-11-29

International Psychogeriatrics

Abstract:Summary: Provide a vision of the current situation of ageing and dementia in Latin America and the Caribbean (LAC). The importance of assessing the needs of people with dementia, supporting families, integrating risk reduction strategies, healthy ageing, promoting training programs to support primary care, and promoting new advances in the Microgliota axis concept will be highlighted—brain intestine. Despite the enormous burden that dementia generates, it continues to be an underdiagnosed entity. It is essential to control its prevalence, incidence, as well as its different social repercussions. It is crucial to promote direct actions aimed at reducing risk, disseminating knowledge of dementia, and promoting new lines of research that contribute to a healthier life for patients and their families. Microglia microbiota aging- Dr A Kabanchik In recent years, research interest arose in microglia-microbiota, normal and pathological aging, and new therapeutics. The Objectives of this presentation is to collaborate with the dissemination of this research and stimulate new developments. Concepts, functions, modifications linked to microglia, microbiota and gut brain axis were defined during the aging process associated with the increase in intestinal permeability, neuroinflammation and its impact on stress, depression and cognitive impairment. During aging, microglia changes from the resting state to the activated state and contributes to the development of neurogenerative diseases. Dystrophic microglia is differentiated, characteristic of aging, from hypertrophic microglia. Dysbiosis of the gut microbiota could lead to increased permeability of the gastrointestinal tract, which induces a higher level of circulating bacterial products. Changes observed in the intestinal microbiota could be the cause or result of neuroinflammation or alterations in the microglia. In older people, microbiota dysbiosis alters the homeostasis of the microenvironment and the status and function of the microglia. Conclusions: The regulation of microglia was proposed as a potentially effective therapeutic strategy in chronic inflammatory pathologies. Remodeling of the brain intestinal axis using psychobiotics appears promising in reversing depressive symptomatology. The continued exploration of the intersection of the microbiota, immunology and biology has great therapeutic promise. Dementia training needs of primary care professionals- Dr Tomás León Background: Chilean guidelines, as most Latin-American and global recommendations, suggest that most people with dementia and their care partners should be managed in primary care. However, the knowledge and confidence of primary care teams in managing dementia is low, and training programs to support primary care are either lacking or unsuccessful in increasing the confidence of primary care teams. Objectives: Create and evaluate an online course on dementia for primary care. Methods: Qualitative research Methods were used, including focus group interviews with health professionals and individual interviews with people with dementia and their care partners to identify the primary needs regarding dementia. An online course was created, and an analysis was performed on the pre and post-course survey results. Results: The primary needs identified by health professionals were the diagnosis process, treatment and interpersonal skills. More than 50% of the sample expressed low confidence in making a diKerential diagnosis. Less than 30% of the sample felt confident in providing post-diagnostic support and non-pharmacological interventions. For people with dementia and care partners' primary needs were diagnosis disclosure and post- diagnosis support. Initial results show improvement in their confidence in diagnosis, treatment, and care and support for caregivers. Conclusions: Our study supported the need for more training in dementia for primary care and identified additional educational content not usually included in standard dementia education. Including the voices of care partners and people with dementia was novel and ensured that dementia training in Chile was informed and tailored to the needs of the people who matter most. Expansion and adaptation for the Latin American public is ongoing. Dementia in Latin America and the Caribbean: situation and future challenges- Cecilia M Serrano, MD, PhD Dementia is a major global health problem that has social and economic repercussions. It is one of the main factors that contribute to producing dependency and disability in older people and, although its prevalence and incidence increase exponentially with age, it is not part of normal aging. Despite the enormous burden that dementia poses, it remains an underdiagnosed disorder. Latin America has great sociocultural diversity and further studies are necessary to identify people with d -Abstract Truncated-

psychiatry,geriatrics & gerontology,psychology, clinical,gerontology
S8: Understanding Dementia, Neurodegenerative Disorders, and neuropsychiatric symptoms in Aging populations from La tin America

Daisy Acosta,Juan de Jesús Llibre Rodríguez,Ana Luisa Sosa,Isaac Acosta,Ivonne Z. Jimenez-Velasquez,Jorge J Llibre Guerra

DOI: https://doi.org/10.1017/s1041610224001066

IF: 7.191

2024-11-29

International Psychogeriatrics

Abstract:Objectives: Dementia presents a growing public health challenge globally and its impact is significantly pronounced in low and middle-income countries (LMICs), including those in Latin America. This symposium aims to present recent findings on the prevalence, impact, and underlying factors of cognitive impairment and neuropsychiatric symptoms in aging populations across Latin America, with a focus on culturally and regionally specific research findings. Methods: The symposium will consolidate data from the 10/66 Dementia Research Group, which has conducted extensive research across various Latin American countries. We integrate results from multiple investigations with over 12,000 elderly participants from six Latin American countries, utilizing cross-sectional and longitudinal Methodsologies. These studies employ the 10/66 Dementia Research Group protocols, among other internationally recognized diagnostic tools, to assess dementia, neurodegeneration and neuropsychiatric symptoms. Results: The symposium will delve into critical yet not well-understood topics. The audience will be first introduced to emerging trends of dementia prevalence and incidence in Latin America and the interaction with different risk factors particular to the region. Second, we will discuss findings from a comprehensive analysis focusing on the prevalence and impact of cognitive impairment and incident dementia in parkinsonism and Parkinson's Disease. The third presentation will focus on the prevalence of neuropsychiatric symptoms across cognitively unimpaired, dementia, and Parkinson's' disease, emphasizing the need to implement systematic screening Methods for early detection from a clinical and public health perspective. The final talk will present data exploring the influence of genetic ancestry alongside social and environmental factors as predictors of dementia risk in Latin America. Conclusions: The findings presented underscore the complex interplay of genetic, social, and environmental factors in the etiology and progression of neurodegenerative and neuropsychiatric conditions in Latin America. The symposium will highlight the critical need for comprehensive public health strategies and enhanced research focus to better understand and address these issues within aging populations.

psychiatry,geriatrics & gerontology,psychology, clinical,gerontology
Ageing and Dementia in Low and Middle Income Countries–using Research to Engage with Public and Policy Makers

Martin Prince,Daisy Acosta,Emiliano Albanese,Raúl L. Arizaga,Cleusa P. Ferri,Mariella Guerra,Yueqin Huang,K. S. Jacob,Ivonne Z. Jiménez‐Velázquez,Juan J. Llibre Rodriguez,Aquiles Salas,Ana Luisa Sosa,Renata Sousa,Richard Uwakwe,Rikus van der Poel,Joseph Williams,Marc Wortmann

DOI: https://doi.org/10.1080/09540260802094712

2008-01-01

International Review of Psychiatry

Abstract:While two thirds of the 24 million people with dementia worldwide live in low and middle income countries, very little research has been conducted to support policy making in these regions. Among the non-communicable diseases, dementia (in common with other chronic NCDs linked more to long-term disability than to mortality) has been relatively under-prioritized. International agreements, plans and policy guidelines have called for an end to ageist discrimination and a focus upon reducing disadvantage arising from poverty and the consequences of ill health. Social protection, access to good quality age-appropriate healthcare and addressing the problem of disability are all key issues. However, as yet, little progress has been made in addressing these concerns. In this review we outline the current international policy agenda for older individuals, and its specific relevance to those with dementia and other disabling non-communicable diseases. We consider the potential for epidemiological research to raise awareness, refine the policy agenda, and promote action, using the example of the dissemination strategy developed by the 10/66 Dementia Research Group.
Systematic Review: Genetic, Neuroimaging, and Fluids Biomarkers for Frontotemporal Dementia Across Latin America Countries

Claudia Duran-Aniotz,Paulina Orellana,Tomas Leon Rodriguez,Fernando Henriquez,Victoria Cabello,María F. Aguirre-Pinto,Tamara Escobedo,Leonel T. Takada,Stefanie D. Pina-Escudero,Oscar Lopez,Jennifer S. Yokoyama,Agustin Ibanez,Mario A. Parra,Andrea Slachevsky

DOI: https://doi.org/10.3389/fneur.2021.663407

IF: 3.4

2021-06-24

Frontiers in Neurology

Abstract:Frontotemporal dementia (FTD) includes a group of clinically, genetically, and pathologically heterogeneous neurodegenerative disorders, affecting the fronto-insular-temporal regions of the brain. Clinically, FTD is characterized by progressive deficits in behavior, executive function, and language and its diagnosis relies mainly on the clinical expertise of the physician/consensus group and the use of neuropsychological tests and/or structural/functional neuroimaging, depending on local availability. The modest correlation between clinical findings and FTD neuropathology makes the diagnosis difficult using clinical criteria and often leads to underdiagnosis or misdiagnosis, primarily due to lack of recognition or awareness of FTD as a disease and symptom overlap with psychiatric disorders. Despite advances in understanding the underlying neuropathology of FTD, accurate and sensitive diagnosis for this disease is still lacking. One of the major challenges is to improve diagnosis in FTD patients as early as possible. In this context, biomarkers have emerged as useful methods to provide and/or complement clinical diagnosis for this complex syndrome, although more evidence is needed to incorporate most of them into clinical practice. However, most biomarker studies have been performed using North American or European populations, with little representation of the Latin American and the Caribbean (LAC) region. In the LAC region, there are additional challenges, particularly the lack of awareness and knowledge about FTD, even in specialists. Also, LAC genetic heritage and cultures are complex, and both likely influence clinical presentations and may modify baseline biomarker levels. Even more, due to diagnostic delay, the clinical presentation might be further complicated by both neurological and psychiatric comorbidity, such as vascular brain damage, substance abuse, mood disorders, among others. This systematic review provides a brief update and an overview of the current knowledge on genetic, neuroimaging, and fluid biomarkers for FTD in LAC countries. Our review highlights the need for extensive research on biomarkers in FTD in LAC to contribute to a more comprehensive understanding of the disease and its associated biomarkers. Dementia research is certainly reduced in the LAC region, highlighting an urgent need for harmonized, innovative, and cross-regional studies with a global perspective across multiple areas of dementia knowledge.

neurosciences,clinical neurology
Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial.

S. Lakoski,B. Brosnihan,D. Herrington

DOI: https://doi.org/10.1016/J.AHJ.2004.11.025

IF: 5.099

2005-11-01

American Heart Journal

Abstract:
Argentina–Alzheimer's Disease Neuroimaging Initiative: pioneering Alzheimer's Research in Latin America and its Implications for Regional Advancement

Jonathan Fernando Cubas Guillen,Patricio Chrem Méndez,Ezequiel Surace,María Eugenia Martin,Florencia Clarens,Julieta Russo,Paula Harris,Noelia Egido,Fernanda Tapajoz,Hernán Chaves,Silvia Vázquez,Horacio Martinetto,Jorge Campos,Ismael Luis Calandri,Gustavo Sevlever,Ricardo F. Allegri

DOI: https://doi.org/10.1002/alz.14285

2024-10-07

Alzheimer s & Dementia

Abstract:The Alzheimer's Disease Neuroimaging Initiative (ADNI) has fostered collaboration among researchers around the world, catalyzing innovation and accelerating progress in the field. In Latin America, this initiative advanced the validation and development of Alzheimer's disease biomarkers for the first time in our region. In 2011, as part of the international ADNI, Argentina‐ADNI (Arg‐ADNI) was founded. The following years were characterized by strong support from entities such as the Alzheimer's Association, transforming into the emergence of several multinational studies focusing on prevention and diagnosis, and treatment of dementias. These studies are heirs to the tradition of Arg‐ADNI: the Dominantly Inherited Alzheimer Network, Latin American Initiative for Lifestyle Intervention to Prevent Cognitive Decline, Longitudinal Early‐Onset Alzheimer's Disease Study, and Initiative for the Study of Down Syndrome and Alzheimer's Disease. These initiatives have contributed significantly to the development of regional research and serve as essential tools for health policy planning in Latin America. Highlights In Latin America, the Alzheimer's Disease Neuroimaging Initiative (ADNI) advanced the validation and development of Alzheimer's disease biomarkers for the first time in our region. ADNI has been the basis that boosted several multinational studies focusing on both prevention and diagnosis, and treatment of dementias (Dominantly Inherited Alzheimer Network, LatAm‐FINGER, LEADS). These initiatives with the support from the Alzheimer's Association have contributed significantly to the development of regional research This is an example of collaboration between high‐income countries with low‐ and middle‐income countries aimed at global scientific development and inclusion.

clinical neurology
P49: Sociodemographic and Clinical Insights into Behavioral Variant Frontotemporal Dementia and Early-Onset Alzheimer's Disease in Colombia: A Comprehensive Study of Patients and Caregivers

Lina M. Zapata-Restrepo,Katherine Possin,Isabel E Allen,Juan C Rivas,Carlos A Dorado,Carlos Miranda,Maria Mercedes Cardozo,Agustin Ibanez

DOI: https://doi.org/10.1017/s1041610224002333

IF: 7.191

2024-11-29

International Psychogeriatrics

Abstract:Objectives: As life expectancy continues to rise globally, the prevalence of dementia is also increasing. However, there is a lack of studies in Latin American countries that describe the sociodemographic and clinical characteristics of dementia patients and their caregivers, potentially overlooking important differences that could impact diagnosis in a diverse population. This study aims to elucidate the sociodemographic characteristics of patients with Behavioral Variant Frontotemporal Dementia (bvFTD) and Early-Onset Alzheimer's Disease (AD), as well as their primary caregivers in Colombia, while also examining the clinical presentation ofdementia. Methods: A total of 83 Colombian participants were included in the study, consisting of 40 healthy controls and 43 individuals previously diagnosed with bvFTD (n = 20) and early-onset AD (n = 23). Diagnoses were established based on the current diagnostic criteria for both conditions. Participants underwent sociodemographic assessments, and a clinical evaluation was conducted. Additionally, caregivers were characterized sociodemographically. Results: Most participants were female (67%) with a mean age of 63 years. Educational levels were comparable between the dementia group (12.4 years) and the control group (12.9 years). A higher proportion of dementia cases were observed in lower socioeconomic status categories (1 to 3). Past medical history of hypertension, type 2 diabetes, and traumatic brain injury was more prevalent in the bvFTD group, whereas coronary disease was more common in the AD group. Initial psychiatric misdiagnosis occurred more frequently in bvFTD (50%) compared to AD (26%), with depression being the most common misdiagnosis in both groups (37.5%), followed by bipolar disorder (25%) and anxiety (25%). Most caregivers were female (70%) with a mean age of 50 years. The most common caregiver-patient relationships were daughter (25.6%) and husband (25.6%), followed by wife (23.3%). The mean educational level of bvFTD caregivers (13.95) was higher than that of AD caregivers (12.87). Conclusions: These findings provide valuable insights into the sociodemographic characteristics of dementia patients and their caregivers in Latin America, a population that is often underrepresented in research. Further exploration of diagnostic variations may be warranted, given the high prevalence of misdiagnosis in this region.

psychiatry,geriatrics & gerontology,psychology, clinical,gerontology
The Protocols for the 10/66 Dementia Research Group Population-Based Research Programme.

Martin Prince,Cleusa P Ferri,Daisy Acosta,Emiliano Albanese,Raul Arizaga,Michael Dewey,Svetlana I Gavrilova,Mariella Guerra,Yueqin Huang,K S Jacob,E S Krishnamoorthy,Paul McKeigue,Juan Llibre Rodriguez,Aquiles Salas,Ana Luisa Sosa,M,Robert Stewart,Richard Uwakwe

IF: 4.5

2007-01-01

BMC Public Health

Abstract:BACKGROUND:Latin America, China and India are experiencing unprecedentedly rapid demographic ageing with an increasing number of people with dementia. The 10/66 Dementia Research Group's title refers to the 66% of people with dementia that live in developing countries and the less than one tenth of population-based research carried out in those settings. This paper describes the protocols for the 10/66 population-based and intervention studies that aim to redress this imbalance.METHODS/DESIGN:Cross-sectional comprehensive one phase surveys have been conducted of all residents aged 65 and over of geographically defined catchment areas in ten low and middle income countries (India, China, Nigeria, Cuba, Dominican Republic, Brazil, Venezuela, Mexico, Peru and Argentina), with a sample size of between 1000 and 3000 (generally 2000). Each of the studies uses the same core minimum data set with cross-culturally validated assessments (dementia diagnosis and subtypes, mental disorders, physical health, anthropometry, demographics, extensive non communicable disease risk factor questionnaires, disability/functioning, health service utilisation, care arrangements and caregiver strain). Nested within the population based studies is a randomised controlled trial of a caregiver intervention for people with dementia and their families (ISRCTN41039907; ISRCTN41062011; ISRCTN95135433; ISRCTN66355402; ISRCTN93378627; ISRCTN94921815). A follow up of 2.5 to 3.5 years will be conducted in 7 countries (China, Cuba, Dominican Republic, Venezuela, Mexico, Peru and Argentina) to assess risk factors for incident dementia, stroke and all cause and cause-specific mortality; verbal autopsy will be used to identify causes of death.DISCUSSION:The 10/66 DRG baseline population-based studies are nearly complete. The incidence phase will be completed in 2009. All investigators are committed to establish an anonymised file sharing archive with monitored public access. Our aim is to create an evidence base to empower advocacy, raise awareness about dementia, and ensure that the health and social care needs of older people are anticipated and met.
Walking the talk for dementia: A unique immersive, embodied, and multi‐experiential initiative

Fernando Aguzzoli Peres,Aline Nogueira Haas,Angga Dwi Martha,Melissa Chan,Michelle Steele,Maria Teresa Ferretti,Ntokozo N. Ngcobo,Stefania Ilinca,Clara Domínguez‐Vivero,Iracema Leroi,Nisha Sajnani,Eduardo R. Zimmer,Alex Kornhuber,Alexandre Kalache,Berrie Holtzhausen,Catarina Tristão‐Pereira,Charlèss Dupont,Dan Cohen,David de Jong,David Facal,Desmond O'Sullivan,Elaine Mateus,Enzo Roso,Evon Estrop,Giulia Gamba,Gustavo San Martin Elexpe,Hector Ulises Diaz Hernández,Helena Quaid,Ishtar Govia,João Barbosa,Joaquina García del Moral,Johnny Miller,José Antonio García García,Kevin Quaid,Laura Navarro,Laura Zúñiga García,Laureen Waters,Lebo Molete,Maria Eugenia Godoy,Maureen Sigauke,Max William de Ataide Schulte,Peter Estrop,Priscilla San Martin Elexpe Cardoso,Randall Perez,Rianna Patterson,Ronika Chakrabarti,Ruth Wong,Sara Marsillas,Shontonese Lowe,Taida Sánchez Rego,Temitope Farombi,Theresa Montgomery,Ton in ‘t Veen,Valli Yanni,Wendy Weidner,Agustin Ibanez

DOI: https://doi.org/10.1002/alz.13644

2024-01-28

Alzheimer s & Dementia

Abstract:Coping with dementia requires an integrated approach encompassing personal, health, research, and community domains. Here we describe "Walking the Talk for Dementia," an immersive initiative aimed at empowering people with dementia, enhancing dementia understanding, and inspiring collaborations. This initiative involved 300 participants from 25 nationalities, including people with dementia, care partners, clinicians, policymakers, researchers, and advocates for a 4‐day, 40 km walk through the Camino de Santiago de Compostela, Spain. A 2‐day symposium after the journey provided novel transdisciplinary and horizontal structures, deconstructing traditional hierarchies. The innovation of this initiative lies in its ability to merge a physical experience with knowledge exchange for diversifying individuals' understanding of dementia. It showcases the transformative potential of an immersive, embodied, and multi‐experiential approach to address the complexities of dementia collaboratively. The initiative offers a scalable model to enhance understanding, decrease stigma, and promote more comprehensive and empathetic dementia care and research.

clinical neurology
Tackling Dementia Globally: the Global Dementia Prevention Program (glodepp) Collaboration

Kit Yee Chan,Davies Adeloye,Kwaku Poku Asante,Clara Calia,Harry Campbell,Samuel O. Danso,Sanjay Juvekar,Saturnino Luz,Devi Mohan,Graciela Muniz-Terrera,Ricardo Nitrini,Maryam Noroozian,Amit Nulkar,Solomon Nyame,Vasudeo Paralikar,Mario A. Parra Rodriguez,Adrienne N. Poon,Daniel D. Reidpath,Igor Rudan,Blossom C. M. Stephan,TinTin Su,Huali Wang,Tam Watermeyer,Heather Wilkinson,Monica Sanches Yassuda,Xin Yu,Craig Ritchie

DOI: https://doi.org/10.7189/jogh.09.020103

2019-01-01

Journal of Global Health

Abstract:ementia neurodegenerative disease 47 million people worldwide. This ure is predicted to rise to 75 million by 2030 and 132 million by 2050 [1]. Currently, the ma-jority of people (approximately 63%) living with dementia are in low- and middle-income countries (LMICs) and due to their large rapidly ageing populations, this number is going to continue to grow. For 1990 and
Care Arrangements For People With Dementia In Developing Countries

Martin James Prince,Seema N. Quraishi,John R M Copeland,Mathew Varghese,T. Murali,L. Srinivasan,Rangaswamy Thara,Ravi Samuel,ES S. Krishnamoorthy,Vikram H. Patel, Sangath,Amit G. Dias,Meenakshi Ajay Verma,B. Anand,Kunnukatil S. Shaji,K. Praveen Lal,Li Shuran,Jin Liu,Helen Chiu,Teresa Chan,Shening Liu,LiYu Tang,Raúl Luciano Arizaga,Ricardo Francisco Allegri,Márcia Scazufca,Paulo Rossi Menezes,Anateresa Ramos-Cerqueira,MariaCristina Miyazaki,Neide A. Micelli Domingos,G. Patricio Fuentes,C. Gustav Rohde,Juan Llibre Rodriguez J De,Tania Laucerique Pardo,Daisy Acosta,Guillermina Rodríguez,Josué Avendaño,Diana Garcia Santana,Ana Luisa Sosa,Yaneth Rodriguez Rodríguez-Agudelo,Irma E. Velázquez-Brizuela,Miguel Ángel MacÍas-Islas,Gloriela R. De Alba,Gloria Grimaldo,Mariella A. Guerra,Marco Víctor González,Ana Carina San Martin,Maria Ximena Palabé,Aquiles Salas,Ciro Gaona Yánez,Richard Uwakwe,F. Olebuezie

DOI: https://doi.org/10.1002/gps.1046

2004-01-01

International Journal of Geriatric Psychiatry

Abstract:Background Rapid demographic ageing will soon lead to large increases in the numbers of persons with dementia in developing countries. This study is the first comprehensive assessment of care arrangements for people with dementia in those regions.Methods A descriptive and comparative study of dementia care; caregiver characteristics, the nature of care provided, and the practical, psychological (Zarit Burden Interview, General Health Questionnaire) and economic impact upon the caregiver in 24 centres in India, China and South East Asia, Latin America and the Caribbean and Africa.Results We interviewed 706 persons with dementia, and their caregivers. Most caregivers were women, living with the person with dementia in extended family households. One-quarter to one-half of households included a child. Larger households were associated with lower caregiver strain, where the caregiver was co-resident. However, despite the traditional apparatus of family care, levels of caregiver strain were at least as high as in the developed world. Many had cutback on work to care and faced the additional expense of paid carers and health services. Families from the poorest countries were particularly likely to have used expensive private medical services, and to be spending more than 10% of the per capita GNP on health care.Conclusions Older people in developing countries are indivisible from their younger family members. The high levels of family strain identified in this study feed into the cycle of disadvantage and should thus be a concern for policymakers in the developing world. Copyright (C) 2004 John Wiley Sons, Ltd.
Prevalence of Dementia in Latin America, India, and China: a Population-Based Cross-Sectional Survey

Juan J. Llibre Rodriguez,Cleusa P. Ferri,Daisy Acosta,Mariella Guerra,Yueqin Huang,K. S. Jacob,E. S. Krishnamoorthy,Aquiles Salas,Ana Luisa Sosa,Isaac Acosta,Michael E. Dewey,Ciro Gaona,A. T. Jotheeswaran,Shuran Li,Diana Rodriguez,Guillermina Rodriguez,P. Senthil Kumar,Adolfo Valhuerdi,Martin Prince

DOI: https://doi.org/10.1016/s0140-6736(08)61002-8

2008-01-01

Abstract:Background Studies have suggested that the prevalence of dementia is lower in developing than in developed regions. We investigated the prevalence and severity of dementia in sites in low-income and middle-income countries according to two definitions of dementia diagnosis.Methods We undertook one-phase cross-sectional surveys of all residents aged 65 years and older (n=14 960) in 11 sites in seven low-income and middle-income countries (China, India, Cuba, Dominican Republic, Venezuela, Mexico, and Peru). Dementia diagnosis was made according to the culturally and educationally sensitive, 10/66 dementia diagnostic algorithm, which had been prevalidated in 25 Latin American, Asian, and African centres; and by computerised application of the dementia criterion from the Diagnostic and Statistical Manual of Mental Disorders (DSM IV). We also compared prevalence of DSM-IV dementia in each of the study sites with that from estimates in European studies.Findings The prevalence of DSM-IV dementia varied widely, from 0.3% (95% CI 0.1-0.5) in rural India to 6.3% (5.0-7.7) in Cuba. After standardisation for age and sex, DSM-IV prevalence in urban Latin American sites was four-fifths of that in Europe (standardised morbidity ratio 80 [95% CI 70-91]), but in China the prevalence was only half (56 [32-91] in rural China), and in India and rural Latin America a quarter or less of the European prevalence (18 [5-34] in rural India). 10/66 dementia prevalence was higher than that of DSM-IV dementia, and more consistent across sites, varying between 5.6% (95% CI 4.2-7.0) in rural China and 11.7% (10.3-13.1) in the Dominican Republic. The validity of the 847 of 1345 cases of 10/66 dementia not confirmed by DSM-IV was supported by high levels of associated disability (mean WHO Disability Assessment Schedule II score 33.7 [SD 28.6]).Interpretation As compared with the 10/66 dementia algorithm, the DSM-IV dementia criterion might underestimate dementia prevalence, especially in regions with low awareness of this emerging public-health problem.Funding Wellcome Trust (UK); WHO; the US Alzheimer's Association; and Fondo Nacional De Ciencia, Y Tecnologia, Consejo De Desarrollo Cientifico Y Humanistico, and Universidad Central De Venezuela (Venezuela).
Challenges in implementation of public policies in aging and dementia in Peru

Monica M. Diaz,Maritza Pintado-Caipa,Patricia J. Garcia

DOI: https://doi.org/10.1371/journal.pgph.0002345

2023-09-08

PLOS Global Public Health

Abstract:Due to population aging and health transitions, people with dementia in Latin America and Caribbean region (LAC) are expected to increase from 7.8 million in 2013 to over 27 million by 2050 [1]. Fragmented healthcare systems in the LAC region make it challenging to provide adequate dementia care. However, implementing preventive interventions to reduce the burden of dementia can help strengthen services for aging populations [2]. It is crucial to establish public policies that allocate governmental resources to implement these strategies.
Integration of Dementia Systems in Central America: A Social Network Approach

Nereide A. Curreri,Dave Griffiths,Louise Mccabe

DOI: https://doi.org/10.5334/ijic.7630

2024-01-01

International Journal of Integrated Care

Abstract:Introduction: Action 3 of the UN Decade of Healthy Ageing plan is to deliver integrated care to improve older adults' lives. Integrated care is vital in meeting the complex needs of people with dementia but little is known about how this is or could be delivered in low and middle income countries (LMIC). This paper provides insights into previously unknown care system structures and on the potential and reality of delivering integrated care in Central America for people with dementia.Methods: A social network analysis (SNA) methodology was adopted to engage with providers of services for older adults and families with dementia in Guatemala, El Salvador, Honduras, Costa Rica and Panama. Sixty-eight (68) semi-structured interviews were completed, 57 with organisations and 11 with families.Results: Across the five countries there was evidence of fragmentation and low integration within the dementia care systems. A variety of services and types of providers are present in all five countries, and high levels of diversified connections exist among organisations of differing disciplines. However, unawareness among network members about other members that they could potentially form active links with is a barrier on the path to integration.Conclusion: This innovative and robust study demonstrates SNA can be applied to evaluate LMIC care systems. Findings provide baselines of system structures and insights into where resources are needed to fortify integration strategies. Results suggest that Central American countries have the building blocks in place to develop integrated care systems to meet the needs of people with dementia, but the links across service providers are opportunistic rather than context based coordinated integration policies.

health care sciences & services,health policy & services
1- Trends in the prevalence of dementia in Latin America and the Caribbean: findings from the 10/66 studies. (Juan J Llibre Rodríguez)

Juan J. Llibre-Rodriguez,Daysi Acosta,Mariella Guerra,Ana Luisa Sosa-Ortiz,Isaac Acosta,Ivonne Z Jiménez Velázquez,Aquiles Salas,Jorge J. Llibre-Guerra,Martin Prince

DOI: https://doi.org/10.1017/s1041610224001078

IF: 7.191

2024-11-29

International Psychogeriatrics

Abstract:Objectives: Population ageing will lead to a dramatic increase in dementia prevalence globally. Recent evidence suggests a decline in dementia incidence in HIC due to increasing education levels and improvements in cardiovascular health. Although, most of the increase will occur in low and middle-income countries (LMICs), there are no recent estimates of dementia prevalence and incidence in LMICs. The present study aimed to examine new trends on dementia prevalence and incidence in Latin-America and associations of socioeconomic determinants and cardiovascular risk factors. Methods: Sample size included older adults from Latin America (Cuba, Dominican Republic [DR], Puerto Rico [PR], and Mexico) drawn from the 10/66 Dementia Research Group study. We compare wave 1 (2003–2006) with wave 3 (2016 – 2019) of 10/66 studies. The main outcome was dementia prevalence relative to previous waves. Dementia diagnosis was determined according to the 10/66 dementia criteria. All the 10/66 waves used the same standardized assessments and protocols. Results: Comparing the first wave (2003 - 2006) with the third wave (2016 - 2019) in four Latin American countries – Cuba, the Dominican Republic, Mexico, and Peru – reveals significant trends in dementia prevalence. Preliminary data suggest an increase in the Dominican Republic, Mexico, and Peru, while Cuba slightly declined, from 12.4 percent in Wave 1 to 10.1 percent in Wave 3. In contrast, the Dominican Republic's age-adjusted prevalence rose from 11.5 percent to 13.6 percent, Peru from 9.2 percent to 16.8 percent, and Mexico from 8.3 percent to 17.1 percent. Despite, improvements in levels of education, increases in dementia prevalence were associated with higher rates of cardiovascular disease and cardiovascular risk factors, including diabetes, hypertension, obesity and heart disease in the later-born cohorts. Self-reported stroke is also rising. Conclusions: The increasing prevalence of dementia in LAC underscores the urgent need for targeted health interventions. Prevention strategies should emerge as a key focus in the battle against dementia in Latin America. Addressing modifiable risk factors can significantly impact the incidence and prevalence ofdementia.

psychiatry,geriatrics & gerontology,psychology, clinical,gerontology
Global Dementia Strategy: Current Stage and Challenges

Liliana Urbina

DOI: https://doi.org/10.1017/s1041610224000942

IF: 7.191

2024-11-29

International Psychogeriatrics

Abstract:Dementia is a critical global health issue affecting more than 55 million people, and this number is projected to rise to nearly 80 million by the end of the decade. It is the seventh leading cause of death, disproportionately affecting women, with most cases occurring in low- and middle- income countries (LMICs). The economic burden of dementia is immense, with annual costs estimated at $1.3 trillion in 2019, expected to more than double by 2030. Half of these costs are due to informal care, primarily provided by women, who face significant impacts on their physical and mental health. Despite its severity, dementia receives insufficient attention. In May 2017, recognizing dementia as a public health priority, the World Health Assembly approved the Global Action Plan on the Public Health Response to Dementia 2017-2025, which serves as a comprehensive blueprint for policymakers, international, regional, and national partners, and the WHO. The plan addresses the issue through seven strategic areas: policy; awareness; risk reduction; diagnosis, treatment, care and support; strengthening health information systems, and research. However, significant gaps remain in diagnostics, national dementia plans, and research. To facilitate the monitoring of the global action plan, WHO has created the Global Dementia Observatory (GDO), a portal that collects national data on 35 key indicators across the seven strategic areas of the global action plan. Complementing the Observatory, WHO launched a Knowledge Exchange Platform, a repository of best practice examples aimed at fostering mutual learning and multidirectional exchange among regions, countries, and individuals, to facilitate global action. The GDO serves as a monitoring and accountability tool, guiding countries in policy implementation and progress tracking. To meet the 2025 targets, accelerated efforts are needed, emphasizing national responses, equitable access to services, and inclusion of people with dementia. Renewed political commitment and robust health information systems are essential to guide effective planning and action.

psychiatry,geriatrics & gerontology,psychology, clinical,gerontology
P35: Older adult's dementia. Implementation of a multidisciplinary day care program in Argentina

C. Feldberg,G. Guyet,M.F. Tartaglini,S. Vilas,M. Butazzi,M. Jacoboni,C. Terán,M. Astudillo,S Kasten

DOI: https://doi.org/10.1017/s1041610224002187

IF: 7.191

2024-11-29

International Psychogeriatrics

Abstract:Background: Day care programs for older adults with dementia is an effective strategy that allows prolonging the functionality of the elderly, their support and that of their family reducing home care costs and delaying the institutionalization of patients with cognitive impairment. Objectives: The aim of the present work is to describe the main goals and the implementation of a multidisciplinary day care program for patients with dementia and their family caregivers in Argentina. Methods: Design: Prospective cohort study. Subjects: 22 patients and their family caregivers, who attend a day care program in Argentina. Instruments: socio-demographic and psychosocial questionnaire of both patient and caregiver (built ad hoc) Patient: MMSE, GDS, HAD-A, PANAS- VRARG, EQ-5D and instrumental and basic abilities of daily living. Family caregiver: Zarit Burden Interview. Procedure: The intervention for patients consists of two different lines of work, one for the patient, and another for the family member. The activities are coordinated by a multidisciplinary group of professionals. Regarding the caregiver, individual orientation interviews and therapeutic group spaces and psycho-educational material are offered. Results: Preliminary data of 22 patients and caregivers, who have taken part in the program so far, indicate that: Patient: median age was years 75,27 old (ds = 9,28), % 63,6 of which are woman. The values obtain in the instrument are: MMSE 22,45 (ds = 4,78) GDS 4,47 (ds = 3,73), HAD-A 3,66 (ds = 3,39), (PANAS -E-VRARG) Negative items 7,70 (ds = 3,11) (PANAS -E-VRARG) Positive ítems 18,7 (ds = 3,13), EQ-5D 77,35 (ds = 16,21) and BHDL 93,63 (ds = 13,10), IHDL 9,1 (ds = 3,31). And for family caregivers the mean age was 65,27 old (ds = 11,37), % 66,71 of which are woman. Caregivers Zarit Burden Interview mean score was 40, 18 (ds = 11,35). Discussion: Our findings concur with those presented in scientific literature and support the WHO recommendations regarding the need to implement multidisciplinary programs for patients with dementia and family caregivers, in order to moderate the impact that providing care for an elderly relative with a neurological disease has on them.

psychiatry,geriatrics & gerontology,psychology, clinical,gerontology
FC49: Alzheimer's Symposium: A Perspective from the Academy

Florencia Velazquez-Morales

DOI: https://doi.org/10.1017/s1041610224001716

IF: 7.191

2024-11-29

International Psychogeriatrics

Abstract:The World Health Organization (WHO) proclaimed September 21 as World Alzheimer's Disease Awareness Day and extended the observance to the entire month. Various awareness campaigns are being conducted around the world, with special emphasis on the importance of education to improve the quality of life for patients, families, and the community at large, and to eliminate stigma and ageism. It is estimated that there are approximately 44 million people worldwide with some form of dementia, while in the United States it reaches 5.4 million. In Puerto Rico, it is estimated that there are approximately 60,000 people with Alzheimer's disease. An AARP study (2021) showed that there are over 500,000 caregivers of older adults, making Puerto Rico one of the top three countries with the largest aging population and the 6th country in the world. While in Latin America and the Caribbean there is a prevalence between 6.2 and 6.5 per 100 adults aged 60 years or older (WHO). This health and social situation require an educated and empowered society to meet the challenges. Muñoz et. al (2023) conducted a qualitative study with caregivers and found that 91% of the participants stated that training would help them provide better care to the elderly. Social work is one of the main disciplines dealing with this social phenomenon and should therefore play a leading role in education and therapeutic intervention. For the past five years, the Department of Social Work at Inter-American University, Metro Campus, has joined and supported the cause through the celebration of the Alzheimer's Symposium: A Perspective from the Academy. This event involves the entire university community, as well as the community at large, which includes caregivers, government and non- profit agencies, and professionals from various disciplines. There will be concurrent lectures, Discussions among local and international professionals, a film forum, poster presentations, artistic expressions, and educational tables. The 6th Symposium will be held on September 20, 2024. The Symposium is promoted through various media. This activity has generated alliances, recommendations and new educational projects that contribute to the well-being of older adults.

psychiatry,geriatrics & gerontology,psychology, clinical,gerontology

[Concept of the management and diagnosis for ischemic cardiomyopathy (ICM)].

PolSim: Automatic Policy Validation via Meta-Data Flow Simulation

Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City

S19: Aging and Dementia problems in Latin America and the Caribbean: education, healthy ageing and recent research linked to microglia and microbiota

S8: Understanding Dementia, Neurodegenerative Disorders, and neuropsychiatric symptoms in Aging populations from La tin America

Ageing and Dementia in Low and Middle Income Countries–using Research to Engage with Public and Policy Makers

Systematic Review: Genetic, Neuroimaging, and Fluids Biomarkers for Frontotemporal Dementia Across Latin America Countries

Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial.

Argentina–Alzheimer's Disease Neuroimaging Initiative: pioneering Alzheimer's Research in Latin America and its Implications for Regional Advancement

P49: Sociodemographic and Clinical Insights into Behavioral Variant Frontotemporal Dementia and Early-Onset Alzheimer's Disease in Colombia: A Comprehensive Study of Patients and Caregivers

The Protocols for the 10/66 Dementia Research Group Population-Based Research Programme.

Walking the talk for dementia: A unique immersive, embodied, and multi‐experiential initiative

Tackling Dementia Globally: the Global Dementia Prevention Program (glodepp) Collaboration

Care Arrangements For People With Dementia In Developing Countries

Prevalence of Dementia in Latin America, India, and China: a Population-Based Cross-Sectional Survey

Challenges in implementation of public policies in aging and dementia in Peru

Integration of Dementia Systems in Central America: A Social Network Approach

1- Trends in the prevalence of dementia in Latin America and the Caribbean: findings from the 10/66 studies. (Juan J Llibre Rodríguez)

Global Dementia Strategy: Current Stage and Challenges

P35: Older adult's dementia. Implementation of a multidisciplinary day care program in Argentina

FC49: Alzheimer's Symposium: A Perspective from the Academy